| Trial ID: | L0898 |
| Source ID: | NCT02201160
|
| Associated Drug: |
N-3 Fatty acid
|
| Title: |
Impact of n-3 Fatty Acid Supplementation on the Metabolic Abnormalities in Children With NAFLD
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease (NAFLD)
|
| Interventions: |
Dietary Supplement: omega 3
|
| Outcome Measures: |
Efficacy of omega 3 PUFA supplementation in NAFLD subjects compared to placebosA composite mesures regarding the improvement of metabolic profile of NAFLD patients
|
| Sponsor/Collaborators: |
St. Justine's Hospital
|
| Gender: |
Male
|
| Age: |
8 Years18 Years
|
| Phases: |
Phase 1/Phase 2
|
| Enrollment: |
30
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
|
| Start Date: |
18/07/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
Canada
|
| URL: |
http://clinicaltrials.gov/show/NCT02201160
|
